Atlas Trials

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

Clinical trial NCT00232154 · COMPLETED

Trial details

NCT number
NCT00232154
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sinusitis
Start date
2005-11-01
Primary completion
2006-06-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.